Chemotherapeutic Drugs Flashcards

1
Q

4 main types of chemotherapeutic drugs

A
  1. DNA-alkylating agents
  2. Anti-metabolites
  3. Microtubule-disrupting agents
  4. Topoisomerase inhibitors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What phase of the cell cycle is targeted by…
a) anti-metabolites
b) microtubule-disrupting agents

A

a) Anti-metabolites target the S phase (interfere with nucleotide synthesis and DNA replication)

b) Microtubule-disrupting agents target the M phase (interfere with the spindle apparatus during cell division)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How do DNA-alkylating agents work?

A
  1. Directly damage the DNA
  2. Add alkyl, methyl or ethyl groups to the DNA, causing the DNA to cross-link
  3. Cross-linked DNA cannot replicate effectively
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Name 2 DNA alkylating agents

A

Cyclophosphamide
Dacarbazine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How does cyclophosphamide (alkylating agent) work?

A

It is a pro-drug that attaches alkyl groups to guanine bases in DNA. This causes:
1. Cross-linking of DNA strands (covalently-bound strands cannot separate for replication)
2. Mismatched base-pairing (replication error)
3. Strand breaks (DNA is unstable, damaged)

All of this makes it hard for cancer cells to divide, eventually killing the.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Dacarbazine is an alkylating agent used to treat…

A
  1. cancer of the lymph system
  2. malignant melanoma (skin cancer)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Alkylating agents (cyclophosphamide and dacarbazine) can be toxic to…

A

Rapidly proliferating cells:
- hematopoietic system
- GI tract
- Gonads

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How can certain patients become resistant to alkylating agents?

A
  1. Via increased inactivation of the drug by nucleophilic “trapping agents”
  2. Via increased DNA repair to offset the damage and replication errors
  3. Via decreased activation of the pro-drug (by down-regulating cytochrome P450)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Name 3 anti-metabolites

A

Methotrexate
5-fluorouracil
Cytarabine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How does methotrexate (anti-metabolite) work?

A

Methotrexate is very similar in structure to folic acid (it is a folate analog) but functions as an antagonist, inhibiting the enzyme dihydrofolate reductase. This disrupts folate metabolism and inhibits thymidilate synthase, so we can no longer produce thymidine. This interferes with DNA and RNA synthesis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What specific enzyme does methotrexate inhibit?

A

Dihydrofolate reductase (which eventually leads to the inhibition of thymidylate synthase)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How do 5-fluorouracil work (anti-metabolite)?

A
  1. It is an analog of uracil (a pyrimidine) and can thus be incorporated into RNA, which messes up RNA processing and function
  2. 5-FU is also a thymidine analog and inhibits the activity of thymidylate synthase, preventing thymidine production.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How does cytarabine work?

A

Cytarabine modifies the sugar in nucleotides to disrupt DNA/RNA structure.
It competes with dCTP (a normal building block) and gets incorporated into the DNA. This causes DNA strand breaks and triggers apoptosis of the cancer cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Name 3 microtubule-disrupting agents

A

Vincristine
Vinblastine
Taxols

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How does vincristine (MTB-disrupting agent) work?

A

It binds tubulin and terminates MTB assembly. This results in microtubule depolymerization and mitotic arrest (cell cannot divide).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How do taxols (MTB-disrupting agents) work?

A

The promote microtubule assembly and inhibit disassembly. Since microtubules must be dynamic for proper chromosome alignment and separation, stabilization halts mitosis (cell cannot divide).

17
Q

Name 2 topoisomerase inhibitors

A

Daunorubicin
Bleomycin

18
Q

How do topoisomerases work and what happens when they are inhibited.

A

Normally, topoisomerases help unwind DNA from its coiled state (which is necessary for DNA replication).
Inhibition of this process leads to DNA strand breaks and cell cycle arrest.

19
Q

How do daunorubicin and bleomycin (topoisomerase inhibitor) work?

A
  1. Inhibits topoisomerase, causing DNA strand breaks
  2. Intercalates into DNA, disrupting replication and transcription
20
Q

What is the principle behind targeted therapies for cancer?

A

To specifically target cancer cells, and not harm healthy normal tissues

21
Q

What is the Philadelphia oncogene?

A

It is a BCR-ABL fusion gene that results from a translocation between chromosomes 9 and 22, which is common in patients with chronic myeloid leukemia (CML). It encodes a constitutively active kinase, which is a very potent oncogene.

22
Q

How does the Gleevec (Imatinib) drug work?

A

Gleevec inhibits the overactive kinase encoded by the Philadelphia gene.
It does so by occupying the ATP-binding site, preventing ATP binding.
This leads to the death of all CML cells with this oncogene.

23
Q

Mainstay drug for diffuse large B cell lymphoma and chronic lymphocytic leukemia (CLL)

A

Rituximab (anti-CD20)

24
Q

How does rituximab work?

A

It targets CD20, a protein found on B cells. It is a monoclonal antibody and by binding CD20, it marks B cells for destruction. Destroys both normal and malignant B cells

25
Explain immune checkpoint blockade therapy
CTLA-4 is an inhibitory receptor that competes with CD28 for binding to B7. When CTLA-4 binds with B7, it inhibits T cells to down regulate the immune response and prevent excessive T cell activation. Certain drugs (ipilimumab) block CDL4-A, enhancing T cell activation (T cells attack cancer cells).
26
Toxic side effects of immune checkpoint blockade therapy
Immune-related adverse events, related to excessive immune activation. Excessive inflammation: rashes, colitis, hepatitis, etc.
27
How does CAR T-cell therapy work?
1. A patient's T cells are harvested. 2. The T cells are engineered to express a chimeric antigen receptor (CAR), which is specific for a target antigen (eg. CD19 in large B cell lymphoma). 3. The modified T cells are expanded in lab. 4. The modified T cells are infused back into the patient and destroy cells with the target antigen.
28
Targeted therapy for Hodgkin lymphoma
Brentuximab vedotin: A monoclonal antibody that targets tumour cells expressing CD30. The antibody is attached to a cytotoxic drug (microtubule disruptor).
29
How does venetoclax work?
Venetoclax targets BCL-2, an anti-apoptotic protein harnessed by cancer cells. By inhibiting this protein, venetoclax enables apoptosis of cancer cells.
30
3 main principles of "classical" cancer therapy
1. High dose: maximize cell killing with tolerable toxicity 2. Intermittent 3. Drug combinations (KEY)
31
Advantage of drug combinations in chemotherapy
Drug combinations reduce toxicity and prevent the acquisition of resistance (different drugs kill cancer cells in different ways)
32
Drug combinations to treat acute lymphoblastic leukemia (ALL)
* Vincristine * Prednisone * Doxorubicin or daunorubicin
33
Drug to treat chronic myeloid leukemia (Philadelphia chromosome)
Imatinib (Gleevec)
34
Drug combinations to treat Hodgkin lymphoma (ABVD)
Doxorubicinb(Adriamycin) Bleomycin Vinblastine Dacarbazine Nivolumab or Pembrolizumab (ABVD)
35
Drug combinations to treat non-Hodgkin lymphoma (R-CHOP)
Rituximab Cyclophosphamide Doxorubicin (aka Hydroxydaunomycin) Vincristine (aka oncovin) Prednisone